https://www.zacks.com/stock/news/2251859/down-63-39-in-4-weeks-here-s-why-gritstone-bio-grts-looks-ripe-for-a-turnaround?cid=CS-ZC-FT-tale_of_the_tape|rsi-2251859
Apr 08, 2024 - Gritstone bio (GRTS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
zc:-1544491553204050899
0
https://www.zacks.com/stock/news/2252481/here-s-why-you-should-invest-in-entera-bio-entx-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252481
Apr 09, 2024 - Here, we discuss some reasons why buying Entera Bio (ENTX) stock now may turn out to be a prudent move.
zc:-1706741624505731906
0
https://www.zacks.com/stock/news/2253383/does-belite-bio-blte-have-the-potential-to-rally-41-14-as-wall-street-analysts-expect?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2253383
Apr 10, 2024 - The consensus price target hints at a 41.1% upside potential for Belite Bio (BLTE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
zc:-6158566842664947001
0
https://seekingalpha.com/news/4089263-jefferies-cuts-instill-bio-to-hold-cites-drug-discontinuation?source=feed_sector_healthcare
Apr 12, 2024 - Jefferies downgraded Instil Bio (TIL) to hold, citing discontinuation of clinical development for the company’s drug candidate ITIL-306.
0
sa:7844323831346689319
0
https://www.fool.com/investing/2024/04/15/is-bluebird-bio-stock-a-buy/?source=iedfolrf0000001
Apr 15, 2024 - This small biotech is struggling to fly -- and investors should probably steer clear.
0
fool:4392996772657535265
0
https://seekingalpha.com/news/4089763-mustang-bio-stock-tumbles-amid-news-of-mass-layoffs?source=feed_sector_healthcare
Apr 15, 2024 - Mustang Bio (MBIO) stock tumbled 27% Monday in the wake of news that the company plans to cut around 81% of its workforce to conserve cash. Read more here.
0
sa:-5260769045929872246
0
https://seekingalpha.com/news/4091115-telesis-bio-stock-slips-amid-new-ceo?source=feed_sector_healthcare
Apr 18, 2024 - Telesis Bio (TBIO) stock slipped as the company promoted its Chief Operating Officer Eric Esser to the CEO role. Read more here.
0
sa:-1196246820117652749
0
https://seekingalpha.com/news/4091083-zura-bio-stock-jumps-on-plans-to-raise-1125m-in-private-financing?source=feed_sector_healthcare
Apr 18, 2024 - Zura Bio (ZURA) shares jumped around 12% after the immunology company entered into subscription agreements for a private placement.
0
sa:-3132837201734179163
0
https://www.zacks.com/stock/news/2263665/entera-bio-ltd-entx-stock-slides-as-market-rises-facts-to-know-before-you-trade?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2263665
Apr 26, 2024 - The latest trading day saw Entera Bio Ltd. (ENTX) settling at $1.98, representing a -1% change from its previous close.
zc:6031178259663694975
0
https://seekingalpha.com/news/4095540-annovis-bio-alzheimers-tumbles-53-data-alzheimers-candidate-buntanetap?source=feed_sector_healthcare
Apr 29, 2024 - Annovis Bio's Alzheimers disease candidate, buntanetap, triggers trading halts as shares fall ~53%, indicating potential disappointment in trial results. Read more here
0
sa:-6607258486227355782
0